U.S., Nov. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07254962) titled 'CApecitabine Prior to TUmor Resection in Ent Oncology (CAPTURE)' on Nov. 16.
Brief Summary: head and neck squamous cell carcinoma (HNSCC) is a type of cancer that affects areas such as the mouth, throat, and voice box. Despite medical progress, little has changed in the care for patients with HPV-negative cancer. The standard care involves surgery followed by radiation or chemotherapy if needed. However, delays in starting treatment - especially beyond six weeks - are linked to worse outcomes. Many patients also experience cancer returning within two years, often making it harder to treat. This study aims to improve outcomes by givi...